article thumbnail

Mad in America’s 10 Most Popular Articles in 2024

Mad in America

During 2024, we published 155 blogs , 244 reviews of scientific findings , 43 personal stories and 41 MIA reports , of which 22 were podcast interviews. Here we highlight the top ten of Mad in Americas most-read blogs and personal stories of 2024. You can become a MIA Supporter for $5 per month or $20 annually.

article thumbnail

Irish Psychiatry Says Chemical Imbalance Is a Figure of Speech—So, What Now?

Mad in America

The World Health Organization (WHO) guidelines on depression treatment are clear: “Antidepressant medications are not needed for mild depression.” What are the drugs doing?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Much of U.S. Healthcare Is Broken: How to Fix It (Chapter 2, Part 2)

Mad in America

In this blog, he addresses the scientific literature on antidepressant efficacy and FDA approval. S ome of the following studies appeared in my book Antidepressants: Science, Magic or Marketing , 1 and in the next section, I will report on some of the more recent depression treatment outcome studies.

article thumbnail

Winding Back the Clock: What If the STAR*D Investigators Had Told the Truth?

Mad in America

However, there was recognition within the NIMH that that the industry-funded trials didn’t necessarily provide evidence of the efficacy of antidepressants in real-world patients, which prompted it to launch the STAR*D study, touting it as the “largest and longest study ever done to evaluate depression treatment.”

article thumbnail

The New York Times Is Now Engulfed in the STAR*D Scandal

Mad in America

This was a story of a great medical advance, and the announced results from the STAR*D trial, heralded by the NIMH as the “largest and longest study ever done to evaluate depression treatment,” fit into that story of medical progress, for it told of 70% of depressed patients becoming “symptom free” after repeated treatments with antidepressants.

article thumbnail

It’s You, It’s Not Me: Treatment Resistant Depression and the Psychiatric Breakup

Mad in America

The eighties and nineties were a depression-treatment renaissance. It is undeniable that it has been helpful for the pharmaceutical industry, which continues to grow yearly, and as of 2022, the antidepressant market has reached $17.02 billion worldwide.

article thumbnail

Critical Psychiatry Textbook, Chapter 16: Is There Any Future for Psychiatry? (Part Five)

Mad in America

In this blog, he discusses the many studies finding poor long-term results with psychiatric drugs and how the drugs lead to a more chronic course for depression and psychosis. Editor’s Note: Over the next several months, Mad in America is publishing a serialized version of Peter Gøtzsche’s book, Critical Psychiatry Textbook.